Recombinant humanized anti-PD-1 monoclonal antibody (JS001) as salvage treatment for advanced gastric adenocarcinoma: Preliminary results of an open-label, multi-cohort, phase Ib/II clinical study
单位:[1]Sun Yat sen Univ Canc Ctr, Guangzhou, Peoples R China[2]Zhejiang Univ Hosp, Hangzhou, Peoples R China[3]Peking Univ Canc Hosp, Beijing, Peoples R China[4]Gen Hosp Chinese Peoples Liberat Army, Beijing, Peoples R China[5]Tongji Hosp, Wuhan, Peoples R China华中科技大学同济医学院附属同济医院[6]Linyi Tumor Hosp, Linyi, Peoples R China[7]Henan Canc Hosp, Zhengzhou, Peoples R China河南省肿瘤医院[8]China Jinagsu Prov Inst Canc Res, China Jinagsu Province I, Jiangsu, Peoples R China[9]Fudan Univ Shanghai Canc Ctr, Shanghai, Peoples R China[10]Harbin Med Univ Canc Hosp, Harbin, Peoples R China[11]Sichuan Univ, W China Hosp, Chengdu, Peoples R China四川大学华西医院[12]Fujian Med Univ, Fuzhou, Peoples R China[13]Tianjin Med Univ Canc Inst & Hosp, Tianjin, Peoples R China[14]China Med Univ, Hosp 1, Shenyang, Peoples R China[15]Canc Hosp Shantou Univ, Med Coll, Shantou, Peoples R China[16]Jiangsu Prov Hosp, Nanjing, Peoples R China江苏省人民医院[17]Shanghai Gen Hosp, Shanghai, Peoples R China[18]Jilin Univ, Affiliated Hosp 1, Changchun, Peoples R China[19]TopAlliance Biosci Inc, Rockville, MD USA